Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats

被引:59
作者
Hartmann, B
Thulesen, J
Hare, KJ
Kissow, H
Orskov, C
Poulsen, SS
Holst, JJ
机构
[1] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen, Denmark
[2] Univ Copenhagen, Panum Inst, Dept Anat, DK-2200 Copenhagen, Denmark
关键词
streptozotocin diabetes; enteroglucagon; intestinal growth factors; L-cells; morphometry;
D O I
10.1016/S0167-0115(02)00013-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Supraphysiological doses of glucagon-like peptide-2 (GLP-2) have been shown to induce intestinal growth by increasing villus height and crypt depth and by decreasing apoptosis, but a physiological effect of GLP-2 has not yet been demonstrated. Earlier, we found elevated levels of endogenous GLP-2 in untreated streptozotocin diabetic rats associated with marked intestinal growth. In the present study, we investigated the role of endogenous GLP-2 for this adaptive response. We included four groups of six rats: (1) diabetic rats treated with saline, (2) diabetic rats treated with non-specific antibodies, (3) diabetic rats treated with polyclonal,GLP-2 antibodies and (4) non-diabetic control rats treated with saline. All animals were treated with once daily intraperitoneal injections for 13 days and killed on day 14. Diabetic rats treated with saline or non-specific antibodies had a significantly (P<0.01) increased area of mucosa (13.00±0.64 and 13.37±0.60 mm(2), respectively) in the proximal part of the small intestine compared with non-diabetic controls (7.97±0.70 mm(2)). In contrast, diabetic rats treated with GLP-2 antibodies had a significantly (P<0.01) smaller increase in area of mucosa in the proximal part of the small intestine (10.84+/-0.44 mm(2)). Antibody treatment had no effect on body weight, blood glucose concentrations and food intake. Thus, blocking of endogenous GLP-2 in a model of adaptive intestinal growth reduces the growth response, providing strong evidence for a physiological growth factor function of GLP-2. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:173 / 179
页数:7
相关论文
共 21 条
  • [1] Alavi K, 2000, J PEDIATR SURG, V35, P847, DOI 10.1053/jpsu.2000.6861
  • [2] Modulation of specific intestinal epithelial progenitors by enteric neurons
    Bjerknes, M
    Cheng, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) : 12497 - 12502
  • [3] ROLE OF GLUCAGON IN MAINTENANCE OF EUGLYCEMIA IN FED AND FASTED RATS
    BRAND, CL
    JORGENSEN, PN
    KNIGGE, U
    WARBERG, J
    SVENDSEN, I
    KRISTENSEN, JS
    HOLST, JJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1995, 269 (03): : E469 - E477
  • [4] BUHL T, 1988, J BIOL CHEM, V263, P8621
  • [5] Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis
    Drucker, DJ
    Yusta, B
    Boushey, RP
    DeForest, L
    Brubaker, PL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1999, 276 (01): : G79 - G91
  • [6] Induction of intestinal epithelial proliferation by glucagon-like peptide 2
    Drucker, DJ
    Ehrlich, P
    Asa, SL
    Brubaker, PL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7911 - 7916
  • [7] Intestinal growth is associated with elevated levels of glucagon-like peptide 2 in diabetic rats
    Fischer, KD
    Dhanvantari, S
    Drucker, DJ
    Brubaker, PL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (04): : E815 - E820
  • [8] In vivo and in vitro degradation of glucagon-like peptide-2 in humans
    Hartmann, B
    Harr, MB
    Jeppesen, PB
    Wojdemann, M
    Deacon, CF
    Mortensen, PB
    Holst, JJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08) : 2884 - 2888
  • [9] Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 rats and mice
    Hartmann, B
    Thulesen, J
    Kissow, H
    Thulesen, S
    Orskov, C
    Ropke, C
    Poulsen, SS
    Holst, JJ
    [J]. ENDOCRINOLOGY, 2000, 141 (11) : 4013 - 4020
  • [10] Structure, measurement, and secretion of human glucagon-like peptide-2
    Hartmann, B
    Johnsen, AH
    Orskov, C
    Adelhorst, K
    Thim, L
    Holst, JJ
    [J]. PEPTIDES, 2000, 21 (01) : 73 - 80